The UK’s teleradiology sector will see continued sustained growth over the next decade as the NHS attempts to deal with its elective care backlog and outsources more and more radiology work.
Global Health Ltd, the parent company of Indian hospital chain Medanta, closed subscription for its IPO on Monday, with a valuation of 22,060m rupees ($274m). The share price has been set at 319 Rs ($3.96). The IPO will consist of new shares worth 5,000m Rs ($62m), and an offer-for-sale of up to 50.8m Rs ($0.63m) worth of shares.
Deal flow is slowing rapidly. HBI hears CVC has postponed the sale of Finland-based occupational and outpatient specialist Mehilainen. The Trilantic sale of Berlin-based mental health specialist Oberberg, and the Nordic sale of European Dental Group are both at risk too. But we hear that the sales of ophtha group Optegra and diagnostic group Rad-X are likely to proceed.
Indian hospital chain Care Hospitals is the subject of a US$1bn+ bidding war between PE firm KKR, Singaporean state holding company Temasek Holdings, and Indian hospital chain Max Healthcare.
HBI understands a portfolio of homes owned by troubled UK elderly care operator Four Seasons will likely have to be split for sale, and some of these homes are not expected to sell until H2 2023.
American investment management firm Elliott has taken a minority stake in Fresenius Helios, the largest hospital group in Europe by revenue. The move prompts fresh questions about Fresenius' new CEO's intentions for the company.
The slump in healthcare listed stocks and downward valuations of private businesses are encouraging potential buyers to examine enticing European healthcare enterprises.
Transform Hospital Group, a financially troubled UK-based medical aesthetics, cosmetic and weight loss surgery-focussed business, has been forced to lay off staff to secure its future.
Dermatology is hot right now. UK private equity firm Palatine has sold its stake in Veincentre, the UK’s largest chain varicose vein treatment provider, to CBPE Capital (another UK private equity group). This follows the acquisition of Dutch dermatology group Mauritskliniek last month.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
